SEARCH

SEARCH BY CITATION

References

  • 1
    Kleihues P, Davis RL, Ohgaki H, Burger PC, Westphal M, Cavenee WK. Diffusely infiltrating astrocytomas. In: Kleihues P, Cavenee WK, eds. WHO classification of tumours of the nervous system. Pathology and genetics. Lyon: IARC Press, 2000. 2226.
  • 2
    Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med 2004; 82: 65670.
  • 3
    Ichimura K, Ohgaki H, Kleihues P, Collins VP. Molecular pathogenesis of astrocytic tumours. J Neurooncol 2004; 70: 13760.
  • 4
    Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 4451.
  • 5
    Dropcho EJ, Soong SJ. The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study. Neurology 1996; 47: 68490.
  • 6
    Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 68929.
  • 7
    van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003; 163: 103343.
  • 8
    Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 602530.
  • 9
    Hemberger M, Cross JC, Ropers HH, Lehrach H, Fundele R, Himmelbauer H. UniGene cDNA array-based monitoring of transcriptome changes during mouse placental development. Proc Natl Acad Sci USA 2001; 98: 1312631.
  • 10
    Kleihues P, Cavenee WK. WHO classification of tumours of the nervous system. Pathology and genetics. Lyon: IARC Press, 2000. 2239.
  • 11
    Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 98216.
  • 12
    Antonicek H, Persohn E, Schachner M. Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration. J Cell Biol 1987; 104: 158795.
  • 13
    Gloor S, Antonicek H, Sweadner KJ, Pagliusi S, Frank R, Moos M, Schachner M. The adhesion molecule on glia (AMOG) is a homologue of the β subunit of the Na,K-ATPase. J Cell Biol 1990; 110: 16574.
  • 14
    Pagliusi S, Antonicek H, Gloor S, Frank R, Moos M, Schachner M. Identification of a cDNA clone specific for the neural cell adhesion molecule AMOG. J Neurosci Res 1989; 22: 11319.
  • 15
    Lecuona E, Luquin S, Avila J, Garcia-Segura LM, Martin-Vasallo P. Expression of the β1 and β2(AMOG) subunits of the Na,K-ATPase in neural tissues: cellular and developmental distribution patterns. Brain Res Bull 1996; 40: 16774.
  • 16
    Gutmann DH, Huang ZY, Hedrick NM, Ding H, Guha A, Watson MA. Mouse glioma gene expression profiling identifies novel human glioma-associated genes. Ann Neurol 2002; 51: 393405.
  • 17
    Senner V, Schmidtpeter S, Braune S, Puttmann S, Thanos S, Bartsch U, Schachner M, Paulus W. AMOG/β2 and glioma invasion: does loss of AMOG make tumour cells run amok? Neuropathol Appl Neurobiol 2003; 29: 3707.
  • 18
    Scheidenhelm DK, Cresswell J, Haipek CA, Fleming TP, Mercer RW, Gutmann DH. Akt-dependent cell size regulation by the adhesion molecule on glia occurs independently of phosphatidylinositol 3-kinase and Rheb signaling. Mol Cell Biol 2005; 25: 315162.
  • 19
    Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R. Apolipoprotein D. Biochim Biophys Acta 2000; 1482: 18598.
  • 20
    Navarro A, Del Valle E, Tolivia J. Differential expression of apolipoprotein d in human astroglial and oligodendroglial cells. J Histochem Cytochem 2004; 52: 10316.
  • 21
    Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, Olek K, Muller HW. Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J 1990; 9: 247984.
  • 22
    Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 2000; 22: 3306.
  • 23
    Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E. Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett 1991; 290: 13941.
  • 24
    Do Carmo S, Seguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 2002; 277: 551423.
  • 25
    Ogawa K, Utsunomiya T, Mimori K, Yamashita K, Okamoto M, Tanaka F, Inoue H, Ikeda Y, Saku M, Murayama S, Mori M. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application. Int J Oncol 2005; 27: 41726.
  • 26
    Hunter S, Weiss S, Ou CY, Jaye D, Young A, Wilcox J, Arbiser JL, Monson D, Goldblum J, Nolen JD, Varma V. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas. Hum Pathol 2005; 36: 98793.
  • 27
    Diez-Itza I, Vizoso F, Merino AM, Sanchez LM, Tolivia J, Fernandez J, Ruibal A, Lopez-Otin C. Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol 1994; 144: 31020.
  • 28
    Hunter S, Young A, Olson J, Brat DJ, Bowers G, Wilcox JN, Jaye D, Mendrinos S, Neish A. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J Neuropathol Exp Neurol 2002; 61: 27581.
  • 29
    Yamato T, Orikasa K, Fukushige S, Orikasa S, Horii A. Isolation and characterization of the novel gene, TU3A, in a commonly deleted region on 3p14.3–>p14.2 in renal cell carcinoma. Cytogenet Cell Genet 1999; 87: 2915.
  • 30
    Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B, Smith DI. Loss of expression of the DRR1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 2000; 27: 110.
  • 31
    Kraemer C, Enklaar T, Zabel B, Schmidt ER. Mapping and structure of DMXL1, a human homologue of the DmX gene from Drosophila melanogaster coding for a WD repeat protein. Genomics 2000; 64: 97101.
  • 32
    Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002; 169: 11029.
  • 33
    Pils D, Horak P, Gleiss A, Sax C, Fabjani G, Moebus VJ, Zielinski C, Reinthaller A, Zeillinger R, Krainer M. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 2005; 104: 241729.
  • 34
    Huang W, Tan D, Wang X, Han S, Tan J, Zhao Y, Lu J, Huang B. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1. Biochem Biophys Res Commun 2006; 339: 16571.
  • 35
    Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002; 8: 2298305.
  • 36
    Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X, Li X, Yi H, Li M, Zhu G, Liang S. Proteome analysis of human lung squamous carcinoma. Proteomics 2006; 6: 54758.
  • 37
    Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 2005; 4: 168696.